Jorge Santana to Stavudine
This is a "connection" page, showing publications Jorge Santana has written about Stavudine.
Connection Strength
0.150
-
Mel?ndez M, Blanco R, Delgado W, Garc?a R, Santana J, Garc?a H, Rosario O, Rodr?guez JF. Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2006 Mar; 50(3):835-40.
Score: 0.071
-
Sension MG, Bellos NC, Johnson J, Sepulveda GE, DeJesus E, Santana JL, Ames MH, Goodwin SD. Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patients. HIV Clin Trials. 2002 Sep-Oct; 3(5):361-70.
Score: 0.056
-
Gross R, Tierney C, Andrade A, Lalama C, Rosenkranz S, Eshleman SH, Flanigan T, Santana J, Salomon N, Reisler R, Wiggins I, Hogg E, Flexner C, Mildvan D. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Arch Intern Med. 2009 Jul 13; 169(13):1224-32.
Score: 0.023